3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
GATA2 Deficiency
1
Brain Neoplasms
1
Astrocytoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Carboplatin
3
fludarabine
2
Radiotherapy, Intensity-Modulated
2
Pemetrexed
2
Cyclophosphamide
2
Cisplatin
2
Cerebral Decortication
2
pembrolizumab
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Platinum
1
Nivolumab
1
Ipilimumab
1
Fluorodeoxyglucose F18
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Vorinostat
×
30 days
×
Clear all
No trials found.